Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 424,042
  • Shares Outstanding, K 100,010
  • Annual Sales, $ 30,480 K
  • Annual Income, $ -96,970 K
  • 60-Month Beta 2.22
  • Price/Sales 65.38
  • Price/Cash Flow N/A
  • Price/Book 10.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.26
  • Number of Estimates 4
  • High Estimate -0.23
  • Low Estimate -0.34
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +23.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.95 +43.73%
on 01/06/20
4.70 -9.79%
on 01/24/20
+0.55 (+14.91%)
since 12/24/19
3-Month
2.09 +102.87%
on 10/31/19
4.70 -9.79%
on 01/24/20
+1.94 (+84.35%)
since 10/24/19
52-Week
1.91 +121.41%
on 10/02/19
5.11 -17.03%
on 01/25/19
-0.77 (-15.37%)
since 01/24/19

Most Recent Stories

More News
SmarTrend Watching for Potential Pullback in Shares of Inovio Pharmaceu After 17.58% Gain

Inovio Pharmaceu (NASDAQ:INO) traded in a range yesterday that spanned from a low of $4.36 to a high of $4.70. Yesterday, the shares gained 17.6%, which took the trading range above the 3-day high of...

INO : 4.24 (+10.42%)
Coronavirus Spooks Global Markets: Winners and Losers

So far, 18 fatalities and more than 600 are affected by coronavirus in China and the virus is spreading across the boundary, spooking investors.

UAL : 81.90 (-3.51%)
DAL : 58.81 (-2.42%)
AAL : 27.64 (-4.03%)
EL : 205.34 (-1.69%)
RCL : 126.51 (-2.38%)
INO : 4.24 (+10.42%)
MRNA : 21.12 (-1.63%)
CODX : 1.88 (-7.39%)
LVMUY : 91.1900 (-1.17%)
CEPI Grant, Government Aid Drive Coronavirus Focused Biotechs

Several public and private organizations are coming forward to develop vaccines for the new coronavirus by funding developmental programs.

INO : 4.24 (+10.42%)
NVAX : 7.80 (+1.83%)
MRNA : 21.12 (-1.63%)
VIR : 19.95 (+17.49%)
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9 million to develop a vaccine against the recently...

INO : 4.24 (+10.42%)
TWST : 21.65 (-0.69%)
Implied Volatility Surging for Inovio (INO) Stock Options

Investors need to pay close attention to Inovio (INO) stock based on the movements in the options market lately.

INO : 4.24 (+10.42%)
Inovio Welcomes Biotech Leader to its Board of Directors

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced the appointment of Jay Shepard to its Board of Directors. Mr. Shepard brings broad healthcare and financial experience to the board given his tenure...

INO : 4.24 (+10.42%)
BLS Pharma Alleges Inovio's Breach of Contract Obstructed Ability to Deliver Testosterone Replacement Therapy for Hypogonadism and the Transgender Community

BLS Pharma, Inc. filed a complaint late last month against Genetronics, Inc. and Inovio Pharmaceuticals, Inc. (NASDAQ: INO), Case No. 30-2019-01119045, for breaching a contract to supply a needle-free...

INO : 4.24 (+10.42%)
Inovio Provides Update on Clinical Program Plans for 2020

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that Inovio's President & CEO, Dr. J. Joseph Kim will present a corporate update of the company's clinical program goals for 2020 at the Biotech Showcase...

INO : 4.24 (+10.42%)
Look for Shares of Inovio Pharmaceu to Potentially Rebound after Yesterday's 1.18% Sell Off

Inovio Pharmaceu (NASDAQ:INO) traded in a range yesterday that spanned from a low of $3.34 to a high of $3.43. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $3.36...

INO : 4.24 (+10.42%)
Inovio Pharmaceu Rises 3.33% on Heavy Volume: Watch For Potential Pullback

Inovio Pharmaceu (NASDAQ:INO) traded in a range yesterday that spanned from a low of $3.23 to a high of $3.46. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of...

INO : 4.24 (+10.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Trade INO with:

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

2nd Resistance Point 4.93
1st Resistance Point 4.59
Last Price 4.24
1st Support Level 4.01
2nd Support Level 3.77

See More

52-Week High 5.11
Last Price 4.24
Fibonacci 61.8% 3.89
Fibonacci 50% 3.51
Fibonacci 38.2% 3.14
52-Week Low 1.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar